Management of ST-segment-elevation myocardial infarction during the coronavirus disease 2019 (COVID-19) outbreak: Iranian"247" National Committee's position paper on primary percutaneous coronary intervention

2019冠状病毒病（COVID-19）疫情期间ST段抬高型心肌梗死的管理：伊朗“247”国家委员会关于直接经皮冠状动脉介入治疗的立场文件

阅读：1

作者：Sadeghipour,Parham,Talasaz,Azita H,Eslami,Vahid,Geraiely,Babak,Vojdanparast,Mohammad,Sedaghat,Mojtaba,Moosavi,Abouzar Fakhr,Alipour-Parsa,Saeed,Aminian,Bahram,Firouzi,Ata,Ghaffari,Samad,Ghasemi,Massoud,Saleh,Davood Kazemi,Khosravi,Alireza,Kojuri,Javad,Noohi,Feridoun,Pourhosseini,Hamid,Salarifar,Mojtaba,Salehi,Mohamad Reza,Sezavar,Hashem,Shabestari,Mahmoud,Soleimani,Abbas,Tabarsi,Payam,Parsa,Amir Farhang Zand,Abdi,Seifollah

期刊：	Catheterization and Cardiovascular Interventions	影响因子：	1.900
时间：	2021	起止号：	2021 Feb 15;97(3):E346-E351
doi：	10.1002/ccd.28889	研究方向：	微生物学、心血管
疾病类型：	心肌梗塞

Abstract

World Health Organization has designated coronavirus disease 2019 (COVID-19) as a pandemic. During the past several weeks, a considerable burden has been imposed on the Iranian's healthcare system. The present document reviewed the latest evidence and expert opinion regarding the management of ST-segment-elevation myocardial infarction during the outbreak of COVID-19 and outlines a practical algorithm for it.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用；引用内容仅为补充信息，不代表本站立场。

2、若认为本页面引用内容涉及侵权，请及时与本站联系，我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容，需注明“来源：[生知库]”并获得授权；使用引用内容的，需自行联系原作者获得许可。

4、投稿及合作请联系：info@biocloudy.com。